Влияние полиморфизма генов семейства глутатион-трансфераз на тяжесть клинических проявлений муковисцидоза
Abstract
Изучение влияния полиморфизма генов GSTT1, GSTM1, GSTP1 и GCLC на тяжесть клинических проявлений муковисцидоза.
About the Authors
О. НовоселоваRussian Federation
Н. Петрова
Russian Federation
Е. Кондратьева
Russian Federation
С. Красовский
Russian Federation
А. Воронкова
Russian Federation
Р. Зинченко
Russian Federation
References
1. Steinke J.W., Payne S.C., Chen P.G., Negri J., Stelow E.B., Borish L. Etiology of nasal polyps in cystic fibrosis: not a unimodal disease. Ann Otol Rhinol Laryngol, 2012, 121 (9): 579-86.
2. Malaria: New Insights for the Healthcare Professional: 2011 Edition; ScholarlyEditionsTM eBook: 12-28.
3. McKone E.F., Shao J., Frangolias D.D., Keener C.L., Shephard C.A., Farin F.M. et al. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med, 2006, 174 (4): 415-9.
4. Franco R., Panayiotidis M.I., Cidlowski J.A. Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive oxygen species formation. J Biol Chem, 2007, 282 (42): 3045-65.
5. Klein Geltink R.I., O’Sullivan D., Pearce E.L. Caught in the cROSsfire: GSH Controls T Cell Metabolic Reprogramming. Immunity, 2017, 46 (4): 525-527.
Review
For citations:
, , , , , . Pharmacogenetics and Pharmacogenomics. 2017;(2):42-43. (In Russ.)